文章摘要
王伟,秦超,卜克,等.参附注射液治疗脓毒症休克 67例疗效观察[J].安徽医药,2022,26(7):1458-1462.
参附注射液治疗脓毒症休克 67例疗效观察
Observation on the curative effect of Shenfu injection in the treatment of 67 patients with septic shock
  
DOI:10.3969/j.issn.1009-6469.2022.07.043
中文关键词: 脓毒症  休克  参附注射液  预后
英文关键词: Sepsis  Shock  Shenfu injection  Prognosis
基金项目:
作者单位
王伟 郑州大学第五附属医院重症医学科河南郑州 450000 
秦超 郑州大学第五附属医院重症医学科河南郑州 450000 
卜克 郑州大学第五附属医院重症医学科河南郑州 450000 
张晶芳 郑州大学第五附属医院重症医学科河南郑州 450000 
王明珠 郑州大学第五附属医院重症医学科河南郑州 450000 
摘要点击次数: 858
全文下载次数: 299
中文摘要:
      目的观察参附注射液( SFI)对脓毒症休克病人临床预后及相关指标的影响。方法回顾性收集 2018年 1月至 2019年 12月住入郑州大学第五附属医院重症医学科符合标准的脓毒症休克病人 147例,根据病人是否给予 SFI治疗分为 SFI组(n= 67)和非 SFI组( n=80),病人的性别、年龄、心率、左心室射血分数( LVEF)、血清脑钠肽( BNP)、平均动脉压( MAP)、去甲肾上腺素( NE)用量、乳酸、 SOFA评分、总胆红素( TBIL)、肌酐( Cr)、血小板( PLT)、引起脓毒症休克的原发感染灶、 ICU住院天数及预后等指标被收集。结果 SFI组与非 SFI组两组一般指标比较,均差异无统计学意义(均 P>0.05)SFI组与非 SFI组 BNP、NE用量、乳酸、 SOFA评分在诊断脓毒症休克第 6天[109.0(74.0,217.0)ng/L、147.5(101.3,327.0)ng/L,0.1,0(0.04,0.20)μg·kg-1·min-1、
英文摘要:
      Objective To observe the effect of Shenfu injection (SFI) improves prognosis and clinical indicators of septic shock pa-tients.Methods The clinical data of 147 patients with septic shock who were met the criteria in the Department of Intensive CareUnit, the Fifth Affiliated Hospital of Zhengzhou University from January 2018 to December 2019 were retrospectively analyzed. Accord-ing to SFI treatment, patients were assigned into SFI group (n=67) and non-SFI group (n=80). Gender, age, heart rate, left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP), mean arterial pressure (MAP), dose of norepinephrine (NE), lactate levels,SOFA score, total bilirubin (TBIL), creatinine (Cr), platelet (PLT), site of infection causing septic shock, ICU stay time and prognosiswere retrospectively collected.Results There were no differences in all the baseline data between SFI group and non-SFI group (P > 0.05). LVEF, BNP, dose of norepinephrine, lactate levels, SOFA score in the SFI group and the non-SFI group on day 6 of diagnosis ofseptic shock [(57.9 ± 6.3)%, (54.7 ± 6.2)%, 109.0 (74.0, 217.0) ng/L, 147.5 (101.3, 327.0) ng/L, 0.10 (0.04, 0.20) μg·kg-1·min-1, 0.30 (0.17, 0.39)μg·kg-1 ·min-1, (1.66 ± 1.53) mmol/L, (2.41 ± 1.46) mmol/L, 7.0 (5.0, 9.0) score, 8.0 (6.0, 10.0) score] were lower than thoseon day 1 [(45.2 ± 6.7)%, (44.1 ± 7.6)%, 459.0 (294.0,935.0) ng/L, 502.0 (224.5,863.8) ng/L, 0.60 (0.40, 0.80) μg·kg-1·min-1, 0.55 (0.45, 0.70) μg·kg-1·min-1, (4.12 ± 1.89) mmol/L, (4.31 ± 1.44) mmol/L, 10.0 (8.0, 13.0) score, 10.0 (8.3, 12.0) score] (P < 0.05), and the indi-cators in SFI group was better than those in non-SFI group [(57.9 ± 6.3)% vs. (54.7 ± 6.2)%, 109.0 (74.0, 217.0)ng/L vs. 147.5 (101.3, 327.0) ng/L, 0.10 (0.04, 0.20)μg·kg-1·min-1 vs. 0.30 (0.17, 0.39)μg·kg-1·min-1, (1.66 ± 1.53)mmol/L vs. (2.41 ± 1.46) mmol/L, 7.0 (5.0, 9.0)score vs. 8.0 (6.0, 10.0) score] (P < 0.05). ICU stay time in SFI group was shorter than that in non-SFI group [(12.8 ± 5.1)day vs.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮